Background: Monoclonal gammopathy of undetermined significance (MGUS) is a plasma cell proliferative disorder that transforms into multiple myeloma and other serious B-cell disorders at an approximate rate of 1% per year; these patients are also at increased risk for fractures.
Patients and methods: We conducted a retrospective, multicenter study of 100 patients from seven community health clinics to gain a better understanding of the work-up, follow-up, and treatment of these patients.
Results: MGUS patients appear to undergo inadequate work-up, follow-up, and treatment in the community setting.
Conclusions: Physicians should adhere to recently established guidelines to ensure that MGUS patients receive optimal care for this condition.
Copyright © 2011. Published by Elsevier Inc.